characteristics.text: SAMD00400672
characteristics.characteristic: External Id
characteristics.text: Institute for Frontier Science Initiative, Kanazawa university
characteristics.characteristic: INSDC center name
characteristics.text: 2021-08-25T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-06-02T09:01:01.707Z
characteristics.characteristic: INSDC last update
characteristics.text: DRS202511
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: DRS202511
characteristics.characteristic: SRA accession
characteristics.text: 1
characteristics.characteristic: biological replicate
characteristics.text: HeLa
characteristics.ontologyTerms: http://www.ebi.ac.uk/efo/EFO_0001185
characteristics.characteristic: cell line
characteristics.text: 3_KLHDC7B knockdown cell
characteristics.characteristic: cell type
characteristics.text: 3_400 ng/ml subtilase cytotoxin (SubAB) wid-type
characteristics.characteristic: dose
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: KLHDC_si_wt_2
characteristics.characteristic: sample name
characteristics.text: 3_16h_treatment
characteristics.characteristic: time
characteristics.text: HeLa cells trasfected with KLHDC7B siRNA and treated with subtilase cytotoxin wild-type
characteristics.characteristic: title
characteristics.text: 3_Escherichia coli subtilase cytotoxin (SubAB)
characteristics.characteristic: treatment